Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Alert

Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

June 21, 2018

Informed Intermediary Doctrine Not Applicable to Industrial Employer and Its Employees

In Rickicki v Borden Chem., 159 AD3d 1457 (4th Dept. 2018), the Appellate Division Fourth Department, declined to apply the sophisticated intermediary doctrine—also referred to as the informed intermediary or knowledgeable intermediary doctrine—in an industrial employer-employee context.

Under the sophisticated intermediary doctrine, a manufacturer is protected from an end user's breach of the strict products liability cause of action for failure to warn if either 1) the manufacturer communicates a sufficient warning to an intermediary relative to the end user or 2) if the intermediary is fully knowledgeable about the risks of the product and is in the best position to warn the end user or take appropriate safety measures. This doctrine has primarily been applied to prescription drugs and medical devices where the intermediary is a physician and the end user is a patient.

In Rickicki, the plaintiffs-workers sought damages for personal injury as a result of exposure to silica dust while working for Dexter Corporation, Hysol Division (Dexter). The defendant-manufacturers moved for summary judgment based on proof that the plaintiffs' employer, Dexter, was knowledgeable about the hazards posed by silica exposure and received proper warnings about them, thus qualifying them as a sophisticated intermediary. The defendants argued that this served as a complete defense to the failure to warn claim.

The defendants relied on case law holding that a manufacturer of prescription medication or medical devices satisfies its duty to warn by communicating a proper warning to a physician, not a warning to a patient. The court agreed and granted summary judgment on this basis. The Fourth Department, however, reversed.

The Fourth Department noted that case law and legal treatises establish that providing a warning to an end user's employer is not always a complete liability defense, especially where the danger posed is significant and the methods for warning the end user are not difficult to incorporate. In Rickicki, the injured workers directly handled bags of silica that did not contain warnings. The court found that the inclusion of warnings would have only imposed a minimal burden. Consequently, the sophisticated intermediary doctrine did not apply.

The Fourth Department went further, finding that the doctrine generally does not apply in an employer-employee context (at least with respect to the facts at issue). The court observed that the doctrine primarily applies to prescription drugs and medical devices and, thus, is predicated on physician-patient privilege. Since Rickicki involved an industrial employer and its workers, which did not implicate the physician-patient privilege, the doctrine did not apply.

Since it was Dexter, not its workers, that was allegedly knowledgeable about the dangers of silica dust inhalation, the Fourth Department declined "to recognize the sophisticated intermediary doctrine on the facts . . . and [concluded] that there [was] a triable issue of fact whether defendants provided adequate warnings to the injured workers."

Products liability defense counsel should be mindful of the limited application of the sophisticated intermediary doctrine when defending manufacturers of products sold to companies that may pose a danger to their workers if not properly warned. Conversely, plaintiffs' counsel should be aware that the doctrine will likely not hinder a failure to warn claim arising out of the industrial employer-employee context.


If you require further information regarding the content of this Legal Alert, please contact Matthew J. Larkin, Chair of the firm's Torts & Products Liability Defense Practice Area, at mlarkin@barclaydamon.com, or Paul Sanders, partner, at psanders@barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

EPA Lists Two New "Forever Chemicals" Under CERCLA

Alerts

NYS Governor Hochul Announces Final RFP for New Certified Community Behavioral Health Clinics

Alerts

The Second Department Affirms Successful Storm in Progress Defense of Slip and Fall Case

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out